Discovery on Target 2007--CHI's Fifth Annual Conference. RNAi for Drug Discovery and Therapeutics
Shen, Y.
IDrugs the investigational drugs journal 10(12): 848-850
2007
ISSN/ISBN: 1369-7056 PMID: 18041677 Document Number: 610020
Document emailed within 1 workday
Related Documents
Lavery, K.S.; King, T.H. 2003: Antisense and RNAi: powerful tools in drug target discovery and validation Current Opinion in Drug Discovery and Development 6(4): 561-569Samarsky, D. 2005: RNAi: From Biology to Therapeutics--Second Annual Conference. 30 January-1 February 2005, Berlin, Germany IDrugs: the investigational drugs journal 8(3): 219-221
Garvey, R. 2006: Target specific seminars in drug discovery--IBC conference. 24-26 April 2006, Berlin, Germany IDrugs: the investigational drugs journal 9(7): 474-475
Kojima, H.; Okabe, T.; Nagano, T. 2013: Open innovation center for drug discovery: a research-supporting network for drug discovery Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica 141(6): 327-332
Fujita, Y. 2013: Innovation by TaNeDS (Take a New challenge of Drug diScovery) collaborative drug discovery project Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica 142(2): 89-95
Young, S.S. 1999: Discovery 99: accelerate and improve the drug discovery process. 26-29 April 1999, San Diego, CA, USA IDrugs: the investigational drugs journal 2(7): 648-649
Lowe, J.A.; Jones, P.; Wilson, D.M. 2009: The importance of target validation in drug discovery and development Current Opinion in Drug Discovery and Development 12(5): 581-584
Imaizumi, Y.; Kaneko, S. 2011: Study on ion channel transporters as a target for the drug discovery Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica 138(6): 227
Płocinska, R.; Korycka-Machala, M.; Plocinski, P.; Dziadek, J. 2017: Mycobacterial DNA Replication as a Target for Antituberculosis Drug Discovery Current Topics in Medicinal Chemistry 17(19): 2129-2142
Braddock, M. 2003: Inflammatory Processes in Drug Discovery - SRI Conference. 22-23 September 2003, Philadelphia, PA, USA IDrugs: the investigational drugs journal 6(11): 1049-1052
Haramura, M. 2007: Application of chemical biology to proteomics in drug target discovery Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica 129(2): 124-128
Golz, S.; Jörg Hüser 2007: Discovery of a New Drug - From Target Identification to Ultra-High-Throughput Screening Clinical Laboratory 53(1-2): 77-79
Dittrich, H.M.; Hahn von Dorsche, H. 1978: The anatomical and histological investigation of the pancreas in the 19th century and till the discovery of insulin (1921). 2. The pancreas research from the discovery of islets (1869) till the discovery of pancreas-diabetes (1889) Anatomischer Anzeiger 143(3): 231-241
Scholl, S.M. 2001: Molecular targets and cancer therapeutics: discovery, biology and clinical applications Idrugs: the Investigational Drugs Journal 4(12): 1357-1360
Ramjee, G.; Doncel, G.F.; Mehendale, S.; Tolley, E.E.; Dickson, K. 2008: Microbicides 2008 conference: from discovery to advocacy Aids Research and Therapy 5: 19
Chen, W.; Gong, R.; Ying, T.; Prabakaran, P.; Zhu, Z.; Feng, Y.; Dimitrov, D.S. 2014: Discovery of novel candidate therapeutics and diagnostics based on engineered human antibody domains Current Drug Discovery Technologies 11(1): 28-40
Dezube, B.J.; Pantanowitz, L.; Aboulafia, D.M. 2004: Management of AIDS-related Kaposi sarcoma: advances in target discovery and treatment Aids Reader 14(5): 236-8 243-4 251-3
Keller, P.A. 2003: Bioactive Discovery in the New Millennium--A Joint RACI, JMGM, FACS and MM2003 Conference. 5-9 February 2003, Lorne, Australia IDrugs: the investigational drugs journal 6(4): 315-317
Alhenc-Gelas, Fçois.; Parmentier, L.; Bisagni, A. 2003: Pharmacogenetic and pharmacogenomic studies. Impact on drug discovery and drug development Therapie 58(3): 275-282
Kashyap, A.; Singh, P.Kumar.; Silakari, O. 2018: Counting on Fragment Based Drug Design Approach for Drug Discovery Current Topics in Medicinal Chemistry 18(27): 2284-2293